Provention Bio Inc PRVB

NAS: PRVB | ISIN: US74374N1028 26/04/2023

24,98 USD (+3,10%)

(+3,10%) 26/04/2023

Grafiek Provention Bio Inc

Grafiek Provention Bio Inc

1 dag1d 3,10%
1 week1w 0,00%
1 maand1m 0,00%
3 maanden3m 0,00%
6 maanden6m 0,00%
1 jaar1j 0,00%
5 jaar5j 516,79%

Provention Bio Inc in het nieuws

Toon enkel gratis nieuws

13 maart 2023 · Provention Bio Cancels Fourth Quarter and Full Year 2022 Earnings Release and Conference Call · Persbericht

3 maart 2023 · Provention Bio Announces the Grant of Inducement Awards · Persbericht

23 februari 2023 · Provention Bio to Report Fourth Quarter and Full Year 2022 Financial Results on March 16, 2023 · Persbericht

13 februari 2023 · Provention Bio Announces Completion of $35 Million Equity Investment from Sanofi US · Persbericht

8 februari 2023 · Provention Bio to Present at the SVB Securities Global Biopharma Conference · Persbericht

3 februari 2023 · Provention Bio Announces the Grant of Inducement Awards · Persbericht

2 februari 2023 · Provention Bio Announces Closing of Second Tranche with Hercules Capital to Support U.S. Commercial Launch of TZIELD® · Persbericht

6 januari 2023 · Provention Bio Announces the Grant of Inducement Awards · Persbericht

5 januari 2023 · Provention Bio Announces Appointment of Rita Jain, M.D., to Board of Directors · Persbericht

2 december 2022 · Provention Bio Announces the Grant of Inducement Awards · Persbericht

Profiel Provention Bio Inc

Gezondheidstechnologie

Medicinale en botanische productie

Website: www.proventionbio.com

Hoofdzetel: Red Bank, New Jersey Verenigde Staten

CEO: Ashleigh Palmer

Werknemers: 82

Aandelen Provention Bio Inc

Effecten: 94,78 miljoen

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe